TAZ Antikörper (Internal Region)

Produktnummer ABIN7224612

Der Kaninchen Polyklonal Anti-TAZ Antikörper wurde für WB und ELISA validiert. Er ist geeignet, TAZ in Proben von Human zu detektieren.

Kurzübersicht für TAZ Antikörper (Internal Region) (ABIN7224612)

Target: TAZ (Tafazzin (TAZ))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TAZ Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Produktdetails anti-TAZ Antikörper

Bindungsspezifität: Internal Region

Verwendungszweck: Tafazzin Polyclonal Antibody

Spezifität: Tafazzin Polyclonal Antibody detects endogenous levels of Tafazzin protein.

Aufreinigung: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

Immunogen: Synthesized peptide derived from the Internal region of human Tafazzin

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000). Not yet tested in other applications.

Kommentare:

Primary Antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Details zu TAZ

Target: TAZ (Tafazzin (TAZ))

Andere Bezeichnung: Tafazzin

Hintergrund: Rabbit Anti-Tafazzin Polyclonal Antibody,TAZ, EFE2, G4.5, Tafazzin, Protein G4.5,TAZ (tafazzin) encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in TAZ have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.,Tafazzin

Molekulargewicht: observerd band 33kDa

Gen-ID: 6901

UniProt: Q16635